Status:
UNKNOWN
Personalized Persistent Atrial Fibrillation Ablation: The PeAF-by-LAWT Trial
Lead Sponsor:
Centro Medico Teknon
Conditions:
Persistent Atrial Fibrillation
Persistent Atrial Fibrillation Longstanding
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators hypothesized that PeAF-by-LAWT, a personalized protocol that uses a contact-force catheter, a multichannel radiofrequency (RF) generator, and integrated LAWT information to adapt the...
Detailed Description
Pulmonary vein isolation (PVI) remains the cornerstone of all catheter-based treatment strategies in atrial fibrillation (AF). Currently, PVI is recommended (class IA indication) after one failed or i...
Eligibility Criteria
Inclusion
- Age \> 18 years.
- Indication for persistent atrial fibrillation ablation.
- Signed informed consent
Exclusion
- Age \< 18 years.
- Pregnancy.
- Previous AF redo procedure.
- Impossibility to perform a pre-procedural CT scan.
- Concomitant investigation treatments.
- Medical, geographical and social factors that make study participation impractical, and inability to give written informed consent. Patient's refusal to participate in the study.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT05396534
Start Date
July 1 2022
End Date
September 30 2024
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Teknon Medical Center
Barcelona, Spain, 08022